N-(4-FLUOROPHENYL)-4-PHENYL-1,3-THIAZOL-2-AMINE, 95%, 5mg

N-[4-[5-(1,3-Benzodioxol-5-yl)-3-methoxy-1H-1,2,4-triazol-1-yl]phenyl]-2-(phenylthio)acetamide, 98%, 50mg

5-Bromo-m-xylene, 98.0%, 100g

2-Tribromomethylquinoline>98.0%(HPLC)(T)5g

1-Benzyl-1-methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 100mg

2-Chloro-5-(trifluoromethyl)isonicotinic acid, 97.0%, 100g

2-(2,4-DIFLUOROPHENYL)-1-(PYRIDIN-3-YL)ETHAN-1-ONE, 95.0%, 500mg

1-(2-Phenylethyl)homopiperazine, 95.0%, 5g

2-Methyl-1-(piperazin-1-yl)propan-2-ol, 98%, 5g

(4-Sulfamoyl-phenoxy)-acetic acid, 250mg

2-Methyl-imidazo[2,1-b]thiazole-5-carboxylic acid ethyl ester, 95%+, 1g

Colonnes de garde HPLC (analytiques) Pyramide NUCLEODUR® C18, 3 pièce(s)

1-(3,4-Dichlorophenyl)propan-1-one, 95.0%, 25g